Resilient coping - Applying adaptive responses to prior adversity during treatment for hepatitis C infection

National Centre in HIV Social Research (NCHSR), Australia.
Journal of Health Psychology (Impact Factor: 1.22). 02/2008; 13(1):17-27. DOI: 10.1177/1359105307084308
Source: PubMed

ABSTRACT Social marginalization is associated with poor health outcomes for affected people. However, in a psychosocial study of treatment for hepatitis C infection conducted in Sydney, Australia, participants living in socially disadvantaged circumstances applied adaptive approaches learned from past experiences of drug dependence, living with symptoms of chronic illness, coping with depression and childhood sexual abuse to enable them to cope with severe treatment-related side-effects. This finding has implications for the clinical management of hepatitis C treatment; the factors and processes that facilitate adaptive coping to adversity associated with social marginalization can be assessed for their clinical contribution to coping with an arduous regimen.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Hepatitis C is a rapidly growing infectious disease in Australia. People with hepatitis C face challenges and need help managing the psychosocial impact of the disease and treatment on their daily lives. A qualitative study design was used to explore social workers' understanding of the psychosocial consequences of the hepatitis C treatment experience and to clarify the roles and suggested practices for social workers dealing with this population. The study findings contribute to the knowledge base about how social workers, on multidisciplinary teams, contribute to meeting the psychosocial needs of people who receive treatment for hepatitis C.
    Journal of Social Work Practice in the Addictions 02/2011; 11(1):40-59. DOI:10.1080/1533256X.2011.546200
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The high prevalence of psychological distress in multiple sclerosis (MS) is well established and it is recognised that the beliefs people form about their neurological condition, and the coping mechanisms they employ, influence their psychological well-being. Acceptance and commitment therapy (ACT) is a third wave cognitive behavioural therapy that focuses on how people relate to their thoughts and engage in valued activities, even in the presence of difficult emotions, fatigue, and pain. To date there has been little clinical research into the application of ACT with people with MS. In this case study we report on a sixty-two-year-old woman with secondary progressive MS who was assessed and treated using an ACT intervention. The treatment involved both individual and couples therapy that focused on how her thoughts about MS and her memories of childhood trauma were impacting upon her current well-being and relationships. Measures of acceptance and psychological distress were gathered pre-, mid-, and post-treatment. At the end of therapy, depression and anxiety scores had reduced to non-clinical levels. She reported improved acceptance of her MS symptoms and related thoughts, and greater engagement in valued activities. She felt more able to take perspective on her trauma memories and to reduce the impact these had on her ability to live successfully with MS. Consideration of the clinical utility of this therapy in MS is made, along with suggestions for further developments in this area.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Globally, it is estimated that 170 million people are living with hepatitis C and between three and four million are newly infected annually. In Australia, around 1% of people are living with chronic hepatitis C, with two-thirds of these being men. This research aimed to determine the impact of hepatitis C treatment on partners of patients using in-depth exploratory techniques. Four infected men and their partners (n= 8 participants) and three service providers were recruited and interviewed separately to identify the needs of female partners supporting patients with Hepatitis C. Discussion was based on the experiences of female partners during the treatment phase of male hepatitis C patients. All participants recognised a need for greater assistance for partners of hepatitis C treatment patients. It was also recognised that strong social support improved treatment outcomes and helped to maintain the survival of family relationships during the intensive treatment phase. Although this research was limited by size, it provides valuable insights into ways to enhance hepatitis C management outcomes beyond traditional medical treatment regimes, for example through formal partner support.
    Australasian Medical Journal 11/2012; 5(11):585-8. DOI:10.4066/AMJ.2012.1442